Last reviewed · How we verify
Placental Membrane
Placental membrane acts as a biological scaffold and immunomodulatory barrier to promote wound healing and tissue regeneration.
Placental membrane acts as a biological scaffold and immunomodulatory barrier to promote wound healing and tissue regeneration. Used for Wound healing and tissue repair, Burn treatment, Surgical reconstruction.
At a glance
| Generic name | Placental Membrane |
|---|---|
| Sponsor | BioXTek |
| Drug class | Biological tissue graft / Regenerative medicine product |
| Modality | Biologic |
| Therapeutic area | Regenerative Medicine / Wound Care |
| Phase | FDA-approved |
Mechanism of action
Placental membrane (typically amniotic or chorion membrane) provides a naturally derived extracellular matrix that supports cell migration and tissue repair while delivering anti-inflammatory and antimicrobial properties. The tissue contains growth factors and cytokines that facilitate healing, and its immunologically privileged nature reduces rejection risk. It is used as a graft or dressing material in regenerative medicine applications.
Approved indications
- Wound healing and tissue repair
- Burn treatment
- Surgical reconstruction
Common side effects
- Infection
- Graft rejection or failure
- Allergic reaction
Key clinical trials
- A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers (NA)
- Evaluation of the Safety and Efficacy of Dehydrated Human Amnion-Intermediate-Chorion Membrane (dHAICM) Allograft vs Standard of Care in the Treatment of Partial Thickness Thermal Burns (PHASE4)
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers (NA)
- Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers (NA)
- Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds (NA)
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers (NA)
- Betamethasone and Severity of Hyaline Membrane Disease
- Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placental Membrane CI brief — competitive landscape report
- Placental Membrane updates RSS · CI watch RSS
- BioXTek portfolio CI